BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34014421)

  • 1. Divergent Dimethylarginine Dimethylaminohydrolase Isoenzyme Expression in the Central Nervous System.
    Kozlova AA; Ragavan VN; Jarzebska N; Lukianova IV; Bikmurzina AE; Rubets E; Suzuki-Yamamoto T; Kimoto M; Mangoni AA; Gainetdinov RR; Weiss N; Bauer M; Markov AG; Rodionov RN; Bernhardt N
    Cell Mol Neurobiol; 2022 Oct; 42(7):2273-2288. PubMed ID: 34014421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C; Mowat F; Sayed H; Mehad M; Duluc L; Piper S; Luhmann U; Nandi M; Kelly P; Smith A; Ali R; Leiper J; Bainbridge J
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X; Atzler D; Xu X; Zhang P; Guo H; Lu Z; Fassett J; Schwedhelm E; Böger RH; Bache RJ; Chen Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redefining the biological and pathophysiological role of dimethylarginine dimethylaminohydrolase 2.
    Nair PC; Mangoni AA; Rodionov RN
    Trends Mol Med; 2024 Jun; 30(6):552-561. PubMed ID: 38553332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase.
    Ragavan VN; Nair PC; Jarzebska N; Angom RS; Ruta L; Bianconi E; Grottelli S; Tararova ND; Ryazanskiy D; Lentz SR; Tommasi S; Martens-Lobenhoffer J; Suzuki-Yamamoto T; Kimoto M; Rubets E; Chau S; Chen Y; Hu X; Bernhardt N; Spieth PM; Weiss N; Bornstein SR; Mukhopadhyay D; Bode-Böger SM; Maas R; Wang Y; Macchiarulo A; Mangoni AA; Cellini B; Rodionov RN
    Nat Commun; 2023 Jun; 14(1):3392. PubMed ID: 37296100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis.
    Lambden S; Kelly P; Ahmetaj-Shala B; Wang Z; Lee B; Nandi M; Torondel B; Delahaye M; Dowsett L; Piper S; Tomlinson J; Caplin B; Colman L; Boruc O; Slaviero A; Zhao L; Oliver E; Khadayate S; Singer M; Arrigoni F; Leiper J
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1382-92. PubMed ID: 25857313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S; Hu CP; Yuan Q; Zhang WF; Zhou Z; Nie SD; Jiang JL; Li YJ
    J Neurosci Res; 2012 Jun; 90(6):1209-17. PubMed ID: 22488726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins.
    Tran CT; Fox MF; Vallance P; Leiper JM
    Genomics; 2000 Aug; 68(1):101-5. PubMed ID: 10950934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
    Ivashchenko CY; Bradley BT; Ao Z; Leiper J; Vallance P; Johns DG
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H251-8. PubMed ID: 19915177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
    PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
    Brites-Anselmi G; Azevedo AMM; Miyazaki AHL; Pinheiro LC; Coeli-Lacchini FB; de Andrade MF; Molina CAF; Tucci S; Hirsch E; Tanus-Santos JE; Lacchini R
    Nitric Oxide; 2019 Nov; 92():11-17. PubMed ID: 31394201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
    Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL.
    Lumicisi BA; Cartwright JE; Leslie K; Wallace AE; Whitley GS
    Hum Reprod; 2015 Aug; 30(8):1813-9. PubMed ID: 26082478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F; Onozato ML; Luo Z; Wilcox CS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.